jefferies' yee favors pfizer and moderna for covid-19 vaccines long-term
Published 3 years ago • 16K plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
3:50
jefferies analyst makes the case for moderna after pfizer and biontech rise on covid-19 vaccine news
-
4:50
moderna's vaccine candidate is a 'home run': jefferies' michael yee
-
1:55
there's absolutely covid stock fatigue: jefferies' michael yee
-
4:12
'tons' of new covid vaccine supply coming by summer: jefferies' yee
-
3:19
melanoma vaccine data should make investors more positive on moderna, says jefferies' michael yee
-
3:50
moderna ceo: plan to file covid and flu combo shot with fda by end of the year
-
6:10
gene munster on what's next for tesla stock
-
4:36
jim cramer on the u.k. approving pfizer's covid-19 vaccine for general use: 'this is monumental'
-
5:26
covid vaccine stocks face 'serious questions' about revenue trajectory: jefferies' michael yee
-
2:36
the biggest wave of covid injections are behind us, says jefferies' michael yee
-
1:21
pfizer forecasts $15 billion in revenue from covid-19 vaccine in 2021
-
5:32
pfizer's covid-19 vaccine should be relatively safe and could be given in december
-
1:56
how moderna's covid-19 vaccine distribution will be different than pfizer's
-
4:49
the stocks with upside amid covid-19 vaccine rollout: bank of america's geoff meacham
-
4:22
covid is going to be a problem for the stocks of vaccine makers, says jefferies' michael yee
-
4:49
moderna's mrna rsv vaccine propels stock gains
-
4:04
moderna ceo: we expect to know if covid-19 vaccine works in november
-
2:52
moderna sues pfizer and biontech for patent infringement over covid vaccine
-
4:19
jefferies' michael yee on heart inflammation linked to covid vaccines
-
3:34
this analyst has concerns about the pfizer and biontech vaccine
-
4:00
fda vaccine committee member explains why he voted yes on pfizer's covid-19 vaccine
-
4:20
pfizer announces covid-19 vaccine partnership